Search - tctmd.com

Displaying 61 - 80 of 428

Sort: Relevancy | Date

Presentation TCT 2024

CV Event Reduction is the Essential Criterion for Implementing New Device Therapies

Presenter: Ori Ben-Yehuda

October 30, 2024

Presentation TCT 2024

Artificial Intelligence-Based Fully Automated Quantitative Coronary Angiography Versus Optical Coherence Tomography Guidance for Coronary Stent Implantation (FLASH)

Presenter: Jung-Min Ahn

October 30, 2024

Presentation TCT 2024

Editorial Comments

Presenter: Akiko Maehara

October 30, 2024

Presentation TCT 2024

Late Clinical Outcomes in Small Annulus Patients in the PARTNER Trials

Presenter: Mahesh Madhavan

October 30, 2024

Presentation TCT 2024

TRISCEND II Trial: Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation

Presenter: Susheel Kodali

October 30, 2024

Presentation TCT 2024

Editorial Comments

Presenter: Vinayak Bapat

October 30, 2024

Presentation TCT 2024

Editorial Comments

Presenter: Neil Fam

October 30, 2024

Presentation TCT 2024

Real World TTVI Registries vs. Randomized Trials: Are the Outcomes Aligned?

Presenter: Brian Whisenant

October 30, 2024

Presentation TCT 2024

Transcatheter Tricuspid Valve Replacement - Lessons Learned From TRISCEND II

Presenter: Charles Davidson

October 30, 2024

Presentation TCT 2024

Editorial Comments

Presenter: Mamas Mamas

October 30, 2024

Presentation TCT 2024

Quantitative Flow Ratio or Fractional Flow Reserve for Guiding Coronary Revascularization

Presenter: Birgitte Krogsgaard Andersen

October 30, 2024

Presentation TCT 2024

Transcatheter Tricuspid Edge-To-Edge-Repair – Updates from TRILUMINATE and TRI-FR

Presenter: Paul Sorajja

October 30, 2024

Presentation TCT 2024

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

Presenter: Michael Reardon

October 30, 2024

Presentation TCT 2024

TCT 346: Assessment of Long-Term Clinical Outcomes of De Novo DCB Performance: Patient Data Meta-Analysis of Randomized Clinical Trials: Final Results of the ANDROMEDA Study

Presenter: Bernardo Cortese

October 30, 2024

Presentation TCT 2024

Lessons Learned From Recent Clinical Trials (EARLY TAVR and AVATAR)

Presenter: Allan Schwartz

October 30, 2024

Presentation TCT 2024

A Critical Review of Clinical Results in Current TMVR Trials: Implications for Patient Selection and Study Design

Presenter: Firas Zahr

October 30, 2024

Presentation TCT 2024

Transcatheter Repair Versus Surgery in Atrial Mitral Regurgitation: Results From the MATTERHORN Trial

Presenter: Stephan Baldus

October 30, 2024

Presentation TCT 2024

DANGER Shock: Impella versus Standard Card for STEMI Patients with Cardiogenic Shock

Presenter: Jacob Moeller

October 30, 2024

Presentation TCT 2024

CLASP IID Randomized Trial and Registry: Two-Year Outcomes of Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation

Presenter: Firas Zahr

October 30, 2024

Presentation TCT 2024

PREVENT

Presenter: Gary Mintz

October 30, 2024

Advertisement

CV Event Reduction is the Essential Criterion for Implementing New Device Therapies

Artificial Intelligence-Based Fully Automated Quantitative Coronary Angiography Versus Optical Coherence Tomography Guidance for Coronary Stent Implantation (FLASH)

Editorial Comments

Late Clinical Outcomes in Small Annulus Patients in the PARTNER Trials

TRISCEND II Trial: Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation

Editorial Comments

Editorial Comments

Real World TTVI Registries vs. Randomized Trials: Are the Outcomes Aligned?

Transcatheter Tricuspid Valve Replacement - Lessons Learned From TRISCEND II

Editorial Comments

Quantitative Flow Ratio or Fractional Flow Reserve for Guiding Coronary Revascularization

Transcatheter Tricuspid Edge-To-Edge-Repair – Updates from TRILUMINATE and TRI-FR

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

TCT 346: Assessment of Long-Term Clinical Outcomes of De Novo DCB Performance: Patient Data Meta-Analysis of Randomized Clinical Trials: Final Results of the ANDROMEDA Study

Lessons Learned From Recent Clinical Trials (EARLY TAVR and AVATAR)

A Critical Review of Clinical Results in Current TMVR Trials: Implications for Patient Selection and Study Design

Transcatheter Repair Versus Surgery in Atrial Mitral Regurgitation: Results From the MATTERHORN Trial

DANGER Shock: Impella versus Standard Card for STEMI Patients with Cardiogenic Shock

CLASP IID Randomized Trial and Registry: Two-Year Outcomes of Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation

PREVENT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content